Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       FORM 8-K   CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): November 19, 2025     THE CLOROX COMPANY (Exact name of registrant as specified in its charter)   Delaware 1-07151 31-0595760 (State or other jurisdiction of (Commission File Number) (I.R.S. Employer incorporation)   Identification No.)   1221 Broadway , Oakland , California 94612-1888 (Address of principal executive offices) (Zip code)   ( 510 ) 271-7000 (Registrant's telephone number, including area code)   Not applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock - $1.00 par value CLX New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 5.07 Submission of Matters to a Vote of Security Holders.   (a) On November 19, 2025, The Clorox Company (the “Company”) held its virtual annual meeting of shareholders.     (b) The shareholders (1) elected all of the Company’s nominees for director, (2) approved the compensation of the Company’s named executive officers on an advisory basis, and (3) ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026.   The final voting results on each of the matters submitted to a vote are as follows:   1. Election of Directors:       Number of Votes     For   Against   Abstain   Broker Non-Votes Gina Boswell   87,241,439   911,643   304,320   16,748,497 Stephen B. Bratspies   87,311,360   828,040   318,002   16,748,497 Pierre R. Breber   86,288,908   1,855,117   313,378   16,748,497 Julia Denman   87,349,899   806,877   300,626   16,748,497 Esther Lee   84,749,929   3,372,071   335,403   16,748,497 A.D. David Mackay   87,066,608   1,080,570   310,224   16,748,497 Stephanie Plaines   86,840,639   1,222,967   393,796   16,748,497 Linda Rendle   81,216,339   6,634,729   606,334   16,748,497 Matthew J. Shattock   87,292,871   850,101   314,430   16,748,497 Russell J. Weiner   85,462,554   2,668,550   326,299   16,748,497 Christopher J. Williams   86,560,378   1,529,347   367,677   16,748,497   2. Advisory Vote on the Approval of Named Executive Officers Compensation: Number of Votes For   Against   Abstain   Broker Non-Votes 79,985,792   7,577,339   894,271   16,748,497   3. Ratification of the selection of Ernst & Young LLP as the Company’s independent auditor for 2026.   Number of Votes For   Against   Abstain   Broker Non-Votes 99,330,452   5,516,058   359,389   0   Item 9.01 Financial Statements and Exhibits   (d) Exhibits   See the Exhibit Index below.   EXHIBIT INDEX   Exhibit   Description       104   Cover Page Interactive Data File (embedded within the Inline XBRL document)       SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.       THE CLOROX COMPANY   Date:   November 20, 2025 By:    /s/ Angela Hilt       Angela Hilt       Executive Vice President - Chief Legal and External Affairs Officer and Corporate Secretary